Subbu Nambi
Stock Analyst at Guggenheim
(4.79)
# 511
Out of 4,361 analysts
157
Total ratings
66.9%
Success rate
27.2%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Reiterated: Buy | $170 → $180 | $162.55 | +10.74% | 11 | Jun 1, 2026 | |
| TEM Tempus AI | Maintained: Buy | $60 | $49.62 | +20.92% | 9 | Jun 1, 2026 | |
| GH Guardant Health | Maintained: Buy | $135 | $130.17 | +3.71% | 14 | May 28, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $75 | $59.90 | +25.21% | 11 | May 26, 2026 | |
| TWST Twist Bioscience | Maintained: Buy | $60 | $70.15 | -14.47% | 8 | May 22, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $100 → $120 | $94.25 | +27.32% | 5 | May 13, 2026 | |
| WAT Waters | Reiterated: Buy | $440 | $371.93 | +18.30% | 5 | May 11, 2026 | |
| MRVI Maravai LifeSciences Holdings | Maintained: Hold | n/a | $4.83 | - | 3 | May 11, 2026 | |
| PSNL Personalis | Maintained: Buy | $13 | $11.14 | +16.70% | 5 | May 7, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $47 | $19.71 | +138.46% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $57.31 | -12.76% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $47.80 | -5.86% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $15.14 | +38.71% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $4.90 | +42.85% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $12 | $15.74 | -23.76% | 4 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $70 | $53.13 | +31.75% | 7 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.68 | +49.25% | 8 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $8.75 | +37.14% | 7 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $275 → $235 | $176.11 | +33.44% | 7 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $270 | $212.73 | +26.92% | 6 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $121.13 | - | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.58 | - | 1 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.12 | - | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $100.39 | - | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €263.00 | $242.90 | +8.28% | 2 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $16.52 | +93.70% | 1 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.31 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $30.71 | n/a | 2 | Feb 23, 2025 |
Illumina
Jun 1, 2026
Reiterated: Buy
Price Target: $170 → $180
Current: $162.55
Upside: +10.74%
Tempus AI
Jun 1, 2026
Maintained: Buy
Price Target: $60
Current: $49.62
Upside: +20.92%
Guardant Health
May 28, 2026
Maintained: Buy
Price Target: $135
Current: $130.17
Upside: +3.71%
GRAIL
May 26, 2026
Reiterated: Buy
Price Target: $75
Current: $59.90
Upside: +25.21%
Twist Bioscience
May 22, 2026
Maintained: Buy
Price Target: $60
Current: $70.15
Upside: -14.47%
BillionToOne
May 13, 2026
Reiterated: Buy
Price Target: $100 → $120
Current: $94.25
Upside: +27.32%
Waters
May 11, 2026
Reiterated: Buy
Price Target: $440
Current: $371.93
Upside: +18.30%
Maravai LifeSciences Holdings
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $4.83
Upside: -
Personalis
May 7, 2026
Maintained: Buy
Price Target: $13
Current: $11.14
Upside: +16.70%
Castle Biosciences
May 7, 2026
Maintained: Buy
Price Target: $47
Current: $19.71
Upside: +138.46%
May 6, 2026
Maintained: Buy
Price Target: $50
Current: $57.31
Upside: -12.76%
May 6, 2026
Reiterated: Buy
Price Target: $45
Current: $47.80
Upside: -5.86%
May 6, 2026
Reiterated: Buy
Price Target: $21
Current: $15.14
Upside: +38.71%
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $4.90
Upside: +42.85%
May 5, 2026
Maintained: Buy
Price Target: $10 → $12
Current: $15.74
Upside: -23.76%
May 4, 2026
Reiterated: Buy
Price Target: $100 → $70
Current: $53.13
Upside: +31.75%
Apr 28, 2026
Reiterated: Buy
Price Target: $4
Current: $2.68
Upside: +49.25%
Apr 27, 2026
Maintained: Buy
Price Target: $12
Current: $8.75
Upside: +37.14%
Apr 21, 2026
Reiterated: Buy
Price Target: $275 → $235
Current: $176.11
Upside: +33.44%
Feb 26, 2026
Reiterated: Buy
Price Target: $270
Current: $212.73
Upside: +26.92%
Feb 24, 2026
Maintained: Hold
Price Target: n/a
Current: $121.13
Upside: -
Feb 12, 2026
Maintained: Hold
Price Target: n/a
Current: $1.58
Upside: -
Oct 28, 2025
Maintained: Hold
Price Target: n/a
Current: $10.12
Upside: -
Oct 27, 2025
Reiterated: Hold
Price Target: n/a
Current: $100.39
Upside: -
Oct 16, 2025
Reiterated: Buy
Price Target: €263.00
Current: $242.90
Upside: +8.28%
Jul 13, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $16.52
Upside: +93.70%
Apr 8, 2025
Downgraded: Hold
Price Target: n/a
Current: $4.31
Upside: n/a
Feb 23, 2025
Maintained: Hold
Price Target: n/a
Current: $30.71
Upside: n/a